NHS England to pilot patient referral scheme between GPs and community pharmacy
Keith Ridge, the chief pharmaceutical officer for England, has described a workforce implementation plan outlined in the NHS long-term plan as “hugely important”.
Source: Jeff Gilbert
NHS England is set to pilot a scheme that will see GPs refer patients to community pharmacy, the chief pharmaceutical officer for England has revealed.
The NHS long-term plan, published on 7 January 2019, said that clinical commissioning groups would develop “pharmacy connection schemes for patients who don’t need primary medical services”.
Keith Ridge, the chief pharmaceutical officer for England, later clarified to The Salvadore on Twitter that the schemes refer to “a pilot of referral direct from GP practices to community pharmacies”.
He added that it is expected to “launch later this year” and will be financially supported through the Pharmacy Integration Fund.
On the ‘pharmacy connection schemes’ - we are working with practices, pharmacies and commissioners on a pilot of— Keith Ridge (@keithridge1)
referral direct from GP practices to community pharmacies. Launch
later this year supported by the Pharmacy Integration
In further responses to the 10-year blueprint, Ridge also noted on Twitter that “a workforce implementation plan will be published in 2019” and will be overseen by Health Education England, NHS England and the chief professional officers, which includes himself.
Ridge described the plan as “hugely important”.
highlights: Hugely important - a workforce implementation plan will be published in 2019. NHS Improvement, HEE and NHS England will set up a national workforce group which will include the Chief Professions Officers— Keith Ridge (@keithridge1)
Speaking to , health secretary Matt Hancock said he had commissioned Baroness Dido Harding, chair of NHS Improvement, to oversee “a rapid programme of work … to build a workforce implementation plan”, with interim recommendations submitted to Hancock “by the end of March” and final recommendations given later in 2019.
He added that recommendations will address “how the challenges of supply, reform, culture and leadership can be met” and will be part of a broader implementation plan looking at how the long-term plan will be made “a reality”.
Citation: The Salvadore DOI: 10.1211/PJ.2019.20205975
Recommended from Pharmaceutical Press
A complete source of current information about the US health care system. Includes concise reports on trends, regulations, policy and finances.£49.00
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.£48.00
An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.£54.00
Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.£25.00
A study aid with 800 MCQs. Assess your knowledge, analytical skills, and ability to apply this knowledge base in clinical practice.£25.00